Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 63330 record(s)

Req # A-2019-001476

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 19-118044-520.

Organization: Health Canada

55 page(s)
May 2022

Req # A-2019-001633

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 19-118044-520.

Organization: Health Canada

55 page(s)
May 2022

Req # A-2020-000086

Adverse Drug Reactions (ADRs) for Celexa. Report numbers: E2B_02757753, E2B_02757783, E2B_02669846, E2B_02675543, 000728695, 000728796, 000728934, E2B_02808449, E2B_02786013, E2B_02790729, E2B_02786012, E2B_02769575, E2B_02778423.

Organization: Health Canada

411 page(s)
May 2022

Req # A-2020-000628

Adverse Drug Reactions (ADRs). Report numbers: 000911946, 000911951.

Organization: Health Canada

22 page(s)
May 2022

Req # A-2020-000852

Adverse Drug Reactions (ADRs). Report numbers: 000915786, 000916101, E2B_03173078.

Organization: Health Canada

15 page(s)
May 2022

Req # A-2020-000866

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-101213-408.

Organization: Health Canada

17 page(s)
May 2022

Req # A-2020-001196

Adverse Drug Reactions (ADRs). Report numbers: E2B_02463884, E2B_02464237, E2B_02464692, E2B_02464792, E2B_02464840, E2B_02464857, E2B 02464872, E2B_02464922, E2B_02465142, E2B_02465214, E2B_02465323, E2B_02465372, E2B_02465412, E2B_02465508, E2B_02465514, E2B_02465517, E2B 02465557, E2B_02465756, E2B_02465777, E2B_02465969.

Organization: Health Canada

241 page(s)
May 2022

Req # A-2020-001333

Adverse Drug Reactions (ADRs). Report numbers: E2B_02759931, E2B_02759940, E2B_02759941, E2B_02759943, E2B_02759944, E2B_02759947, E2B 02759950, E2B_02759958, E2B_02759961, E2B_02759963, E2B_02759965, E2B_02759966, E2B_02759968, E2B_02759969, E2B_02759972, E2B_02759975, E2B 02759978, E2B_02759979, E2B_02759981, E2B_02759983.

Organization: Health Canada

360 page(s)
May 2022

Req # A-2020-001771

Adverse Drug Reactions (ADRs) for Prevegyne. Report numbers: E2B_03441760, E2B_03481583, E2B_03467903, E2B_03470780, E2B_03480519.

Organization: Health Canada

254 page(s)
May 2022

Req # A-2020-001887

Adverse Drug Reaction (ADR) for Nerlynx. Report number: E2B_03438884.

Organization: Health Canada

30 page(s)
May 2022
Date modified: